4th Quarter - Report

FORBES-TATE for NOVARTIS, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues related to prescription drug pricing, the United States-Mexico-Canada Agreement (USMCA), and Intellectual Property (IP).

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

Issues related to prescription drug pricing, the United States-Mexico-Canada Agreement (USMCA), and Intellectual Property (IP).

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to prescription drug pricing, the United States-Mexico-Canada Agreement (USMCA), and Intellectual Property (IP); Issues related to Medicare, Medicaid, Cell and Gene Therapies.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Issues related to prescription drug pricing, the United States-Mexico-Canada Agreement (USMCA), and Intellectual Property (IP).

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Issues related to prescription drug pricing, the United States-Mexico-Canada Agreement (USMCA), and Intellectual Property (IP).

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.